Recent Insider Transactions • 20h
Chief Investment Officer & Director recently bought US$995k worth of stock On the 11th of June, Thomas Knott bought around 85k shares on-market at roughly US$11.67 per share. This transaction increased Thomas' direct individual holding by 2x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold US$1.2m more in shares than they bought in the last 12 months. Live-Nachrichten • Jun 16
GPGI Stock Slides 26% As Law Firm Investigates Securities Law Concerns Robbins Geller Rudman & Dowd LLP has opened an investigation into GPGI, Inc. for potential violations of U.S. federal securities laws.
The probe follows GPGI’s May 7, 2026 disclosure of weaker-than-expected financial results.
After that disclosure, GPGI stock fell about 26%, and the law firm is encouraging investors and potential witnesses to contact them.
An active securities law investigation like this can signal increased legal and reputational risk around GPGI, which many investors factor into how they view the stock.
Anyone with exposure to GPGI may want to follow case updates closely, review their own documentation around the May 7 disclosure, and consider how potential legal outcomes might affect future financial flexibility and management focus. Live-Nachrichten • Jun 08
GPGI Faces Q1 Loss After Husky Deal as Shareholders Approve Move to Nevada GPGI reported mixed Q1 2026 results following its $5 billion Husky Technologies acquisition, with record sales and margin expansion at CompoSecure but volume and margin pressures at Husky contributing to a consolidated GAAP net loss of $235 million.
The company recorded a $154.1 million loss related to the equity method investment from the Husky deal, while GPGI Holdings generated $407.8 million in net sales and $88.8 million in Adjusted EBITDA for the quarter.
Shareholders approved GPGI’s reincorporation from Delaware to Nevada, adopting new Articles of Incorporation and Bylaws that change certain shareholder rights, while the Class A common stock continues to trade on the NYSE under the ticker GPGI.
The mix of a sizeable net loss tied to the Husky acquisition, solid Adjusted EBITDA and governance changes through Nevada reincorporation puts the focus on how effectively GPGI integrates Husky while managing risk and cost controls.
You may want to pay close attention to management’s commentary on the May 7 earnings call regarding Husky’s margin pressures, planned cost actions and any implications of the new corporate structure for shareholder rights and capital allocation. Price Target Changed • May 15
Price target decreased by 13% to US$22.00 Down from US$25.17, the current price target is an average from 3 analysts. New target price is 82% above last closing price of US$12.10. Stock is down 5.5% over the past year. The company is forecast to post earnings per share of US$0.79 next year compared to a net loss per share of US$1.23 last year. New Risk • May 07
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$78m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$78m free cash flow). Shareholders have been substantially diluted in the past year (183% increase in shares outstanding). Revenue is less than US$1m (US$24k revenue). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change). Reported Earnings • May 07
First quarter 2026 earnings released: US$1.85 loss per share (vs US$0.21 profit in 1Q 2025) First quarter 2026 results: US$1.85 loss per share (down from US$0.21 profit in 1Q 2025). Net loss: US$235.0m (down US$256.5m from profit in 1Q 2025). Revenue is forecast to grow 75% p.a. on average during the next 2 years, compared to a 10.0% growth forecast for the Tech industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 126 percentage points per year, which is a significant difference in performance. Ankündigung • May 01
GPGI, Inc. to Report Q1, 2026 Results on May 07, 2026 GPGI, Inc. announced that they will report Q1, 2026 results at 9:30 AM, US Eastern Standard Time on May 07, 2026 Ankündigung • Apr 27
GPGI, Inc., Annual General Meeting, Jun 11, 2026 GPGI, Inc., Annual General Meeting, Jun 11, 2026. Reported Earnings • Mar 13
Full year 2025 earnings: EPS exceeds analyst expectations Full year 2025 results: US$1.23 loss per share (further deteriorated from US$1.22 loss in FY 2024). Revenue: US$59.8m (down 86% from FY 2024). Net loss: US$136.0m (loss widened 153% from FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 9.5%. Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 7.7% growth forecast for the Tech industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 128 percentage points per year, which is a significant difference in performance. Ankündigung • Mar 05
Resolute Holdings Management, Inc. and GPGI, Inc. Appoints David Marshall Chief Legal Counsel and Corporate Secretary, Effective March 30, 2026 Resolute Holdings Management, Inc. announced the appointment of David A.P. Marshall as Chief Legal Counsel and Corporate Secretary of Resolute Holdings and GPGI, effective March 30, 2026. Mr. Marshall will report to Tom Knott, Chief Executive Officer of Resolute Holdings. Mr. Marshall joins Resolute Holdings after serving as a Partner of Paul, Weiss, Rifkind, Wharton & Garrison LLP in New York City, where he advised public companies on complex transactions and capital markets matters for nearly a decade. He earned a J.D. and M.P.P. from the University of Toronto and a B.A. from McGill University. Ankündigung • Mar 02
GPGI, Inc. to Report Q4, 2025 Results on Mar 12, 2026 GPGI, Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 12, 2026 Ankündigung • Feb 03
GPGI, Inc. Declares Quarterly Dividend, Payable on February 27, 2026 GPGI, Inc. announced its Board of Directors has declared a quarterly cash dividend of $0.0025 per share of the Company’s Class A common stock. The dividend represents an annual distribution of approximately $2.9 million. The cash dividend will be payable on February 27, 2026, to shareholders of record of Class A common stock at the close of business on February 13, 2026. Buy Or Sell Opportunity • Jan 07
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 3.2% to US$19.66. The fair value is estimated to be US$24.62, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.8% over the last 3 years. Earnings per share has declined by 38%. Buy Or Sell Opportunity • Dec 15
Now 20% undervalued Over the last 90 days, the stock has risen 1.2% to US$19.64. The fair value is estimated to be US$24.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.8% over the last 3 years. Earnings per share has declined by 38%. Buy Or Sell Opportunity • Nov 17
Now 23% undervalued Over the last 90 days, the stock has risen 4.8% to US$19.08. The fair value is estimated to be US$24.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.8% over the last 3 years. Earnings per share has declined by 38%. New Risk • Nov 04
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 52% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (52% increase in shares outstanding). Minor Risk Significant insider selling over the past 3 months (US$3.5m sold). Reported Earnings • Nov 04
Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2025 results: US$1.58 loss per share (further deteriorated from US$1.10 loss in 3Q 2024). Net loss: US$174.7m (loss widened 315% from 3Q 2024). Revenue exceeded analyst estimates by 3.6%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Tech industry in the US. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings. Ankündigung • Nov 03
Composecure, Inc. Announces That Delara Zarrabi Are Expected to Join the Board of Directors CompoSecure, Inc. announced that Samson and Platinum Equity Managing Director Delara Zarrabi are expected to join the company Board of Directors. Ankündigung • Oct 28
CompoSecure, Inc. to Report Q3, 2025 Results on Nov 10, 2025 CompoSecure, Inc. announced that they will report Q3, 2025 results on Nov 10, 2025 Price Target Changed • Oct 23
Price target increased by 9.4% to US$21.33 Up from US$19.50, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of US$20.62. The company is forecast to post earnings per share of US$0.36 next year compared to a net loss per share of US$1.22 last year. Price Target Changed • Oct 15
Price target increased by 8.8% to US$20.67 Up from US$19.00, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of US$20.49. The company is forecast to post earnings per share of US$0.36 next year compared to a net loss per share of US$1.22 last year. Ankündigung • Oct 10
CompoSecure, Inc. Announces Chief Financial Officer Changes On October 9, 2025, CompoSecure, Inc. announced the appointment of Mary Holt as Chief Financial Officer (CFO), effective the day immediately following the filing of the Company's Third Quarter 2025 Quarterly Report. She succeeds Tim Fitzsimmons who is retiring after a distinguished career with the company. As CFO, Ms. Holt will oversee CompoSecure’s finance organization, including financial planning and analysis; accounting and financial reporting; treasury and cash management; risk management and compliance; and investor relations. She will report directly to Jon Wilk, President and Chief Executive Officer of CompoSecure. Holt brings more than three decades of relevant financial leadership experience to CompoSecure. Ms. Holt, 52, served as Senior Vice President, Finance Operations, Utilities & Power SBG of Warren Equity Partners, a private equity firm, from October 2024 until October 2025. Previously, she served for over 17 years at Honeywell International, Inc., a multinational conglomerate, in roles of increasing responsibility, including most recently as Vice President, Business Analysis & Planning from January 2023 to July 2024, Chief Financial Officer, Productivity Solutions & Services from May 2020 to December 2022, and Chief Financial Officer, Corporate Entities and Functions, from November 2018 to May 2020. Earlier in her career, Holt held leadership positions at Pfizer and Arthur Andersen, further broadening her accounting and operational expertise. She earned her MBA from Duke University and holds a Bachelor of Science in Economics and a Bachelor of Science in Engineering from the University of Pennsylvania. Tim Fitzsimmons will continue to serve in an advisory role to ensure a smooth transition. Price Target Changed • Oct 06
Price target increased by 8.3% to US$19.50 Up from US$18.00, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of US$19.80. The company is forecast to post earnings per share of US$0.36 next year compared to a net loss per share of US$1.22 last year. Board Change • Sep 25
High number of new directors There are 8 new directors who have joined the board in the last 3 years. Independent Director Kevin Moriarty was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Ankündigung • Sep 23
CompoSecure, Inc.(NYSE:CMPO) dropped from NASDAQ Composite Index CompoSecure, Inchas been dropped from the NASDAQ Composite Index. Ankündigung • Aug 28
CompoSecure Highlights Its Arculus Onchain Tap-To-Pay Capability and Showcases Innovation At Stablecoin Conference LATAM 2025 CompoSecure, Inc. announced it will showcase its Arculus direct onchain tap-to-pay capability and that its Head of Arculus Product will share these advancements at Stablecoin Conference LATAM 2025. Arculus direct onchain tap theto-pay helps ensure a seamless bridge between the crypto economy and real-worldcommerce, unlocking new opportunities for adoption at scale. The Arculus solution enables the ability to pay directly onchain and use digital assets seamlessly at traditional point-of-sale (POS) merchant terminals. In addition, the solution supports multifunctional capabilities on a single chip, which means this enables tap-to-pay transactions across both blockchain networks and traditional payment rails, all with the same physical card. By bridging crypto and existing payment infrastructure, Arculus creates tangible value for stakeholders within the payments chain: For POS Providers: Arculus offers a direct integration with existing POS systems, requiring no new hardware investment. This empowers providers to future-proof their platforms, expand their service offerings, and stay competitive by enabling crypto payments alongside traditional card payments. For Merchants can now accept crypto payments instantly through the same contactless infrastructure they already use. This reduces friction at checkout, opens access to a fast-growing global base of crypto users, and provides the opportunity to attract new customers who prefer digital assets. Additionally, onchain payments can lower transaction costs and settlement times compared to legacy payment networks. For Wallet Providers and Consumers: With Arculus's wallet integration, any wallet provider can deliver a tap-to-pay experience directly to users. This allows consumers to spend their digital assets as easily as tapping a phone, all while retaining the benefits of self-custody, speed, and security inherent to blockchain transactions. Ankündigung • Jul 24
CompoSecure, Inc. to Report Q2, 2025 Results on Aug 07, 2025 CompoSecure, Inc. announced that they will report Q2, 2025 results on Aug 07, 2025 Ankündigung • May 13
CompoSecure, Inc. Reiterates Consolidated Earnings Guidance for the Full Year of 2025 CompoSecure, Inc. reiterated consolidated earnings guidance for the full year of 2025. For the year, the company expects mid-single digit growth in consolidated net sales with sales momentum building through the year. This guidance includes payment of the Resolute Holdings management fee in 2025 and 2024, on a pro forma basis. Ankündigung • Apr 04
CompoSecure, Inc., Annual General Meeting, May 28, 2025 CompoSecure, Inc., Annual General Meeting, May 28, 2025. Ankündigung • Mar 08
CompoSecure, Inc. Announces Resignation of Roger Fradin as A Director of the Board CompoSecure, Inc. announced that on February 28, 2025 Roger Fradin notified of his decision to resign as a director of the Board, effective immediately. Mr. Fradin’s resignation is for personal reasons and not as a result of any disagreement with management or any matter relating to the Company’s operations, policies or practices. Ankündigung • Mar 06
CompoSecure, Inc. Provides Earnings Guidance for 2025 CompoSecure, Inc. provided earnings guidance for 2025. For the period, the company expects mid-single digit growth in Net Sales. Ankündigung • Mar 01
CompoSecure, Inc. completed the Spin-Off of Resolute Holdings Management, Inc. (NasdaqGM:RHLD). CompoSecure, Inc. agreed to Spin-Off Resolute Holdings Management Inc. on December 30, 2024. The spin-off of Resolute Holdings will be on a pro rata basis to all existing shareholders of CompoSecure, meaning each existing shareholder will receive an allocation of shares in Resolute Holdings proportional to their current ownership in CompoSecure. As per the transaction, each CompoSecure stockholder will receive one share of our common stock for every twelve shares of CompoSecure common stock held at close of business on the record date of February 20, 2025. The distribution of shares in Resolute Holdings will give rise to a taxable gain to CompoSecure and will be treated as a taxable dividend to all existing shareholders for U.S. federal and applicable state and local tax purposes. Resolute Holdings will be led by David Cote as Executive Chairman of the Board of Directors and Tom Knott as Chief Executive Officer. In addition to David Cote and Tom Knott, the Board of Directors will include John Cote, Joseph DeAngelo, Roger Fradin, Paul Galant, Brian Hughes, Mark James, Krishna Mikkilineni, and Jane Thompson. Resolute Holdings is expected to trade under the ticker “RHLD” on Nasdaq following completion of the spin-off. The spin-off is subject to customary conditions, including the effectiveness of Form 10 registration with the Securities and Exchange Commission and final approval by CompoSecure’s Board of Directors. The record date for shareholders of CompoSecure to receive shares of Resolute Holdings has been set as February 20, 2025 and the distribution is expected to occur prior to the opening of trading on February 28, 2025
Goldman Sachs & Co. LLC, acted as a financial advisor, Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as a legal advisor to CompoSecure. Continental Stock Transfer & Trust Company acted as registrar to Resolute holdings.
CompoSecure, Inc. completed the Spin-Off Resolute Holdings Management Inc. on February 28, 2025. Resolute Holdings common stock will begin trading today on Nasdaq under the ticker symbol “RHLD.” CompoSecure common stock will continue to trade on the Nasdaq under the ticker symbol “CMPO.” Ankündigung • Feb 27
CompoSecure, Inc. to Report Q4, 2024 Results on Mar 05, 2025 CompoSecure, Inc. announced that they will report Q4, 2024 results on Mar 05, 2025 Ankündigung • Nov 08
CompoSecure, Inc. Revises Earnings Guidance for the Year 2024 CompoSecure, Inc. revised earnings guidance for the year 2024. For the year, the company is revising Net Sales guidance to $418 million - $424 million (previously $418 million - $428 million). Ankündigung • Oct 25
CompoSecure, Inc. to Report Q3, 2024 Results on Nov 08, 2024 CompoSecure, Inc. announced that they will report Q3, 2024 results on Nov 08, 2024 Ankündigung • Oct 22
CompoSecure, Inc. Announces the Appointment of Dr. Krishna Mikkilineni to Its Board of Directors CompoSecure, Inc. announced the appointment of Dr. Krishna Mikkilineni to its Board of Directors (Board), effective 21 October 2024. Dr. Mikkilineni brings a wealth of experience in operations and technology, along with a proven ability to deliver success for leading global organizations such as Honeywell. His exceptional business acumen and extensive global expertise will enhance ability to drive growth, accelerate operational excellence, and expand international opportunities. Dr. Mikkilineni currently serves as General Partner of a deep tech venture fund and a startup accelerator, roles he has held since 2019, and in which he has been instrumental in funding and growing 30 technology-driven startup companies. Prior to May 2019, Dr. Mikkilineni served in various roles of increasing seniority at Honeywell International, Inc. for over 33 years, including as global Chief Technology Officer, a role he held for nine years, and as global Integrated Supply Chain Officer and Chief Information Officer, roles he held for six years. Prior to that, Dr. Mikkilineni established Honeywells engineering operation in India eventually growing the global engineering force to over 11,000 with half focused on software. Dr. Mikkilineni received his Ph.D. in electrical and computer engineering from the University of Florida. Dr. Mikkilineni replaces Niloo Razi Howe who recently resigned from the Board due to personal reasons. Ankündigung • Sep 18
Resolute Holdings I, LP completed the acquisition of 60% stake in CompoSecure, Inc. (NasdaqGM:CMPO) for approximately 370 million. Resolute Holdings I, LP agreed to acquire 60% stake in CompoSecure, Inc. (NasdaqGM:CMPO) for approximately 370 million on August 7, 2024. Under the terms of the SPA, the selling shareholders will exchange the entirety of their Class B units and associated Class B shares for Class A shares, eliminating the current dual-share class structure. Resolute will subsequently purchase 49.3 million of the corresponding Class A shares to acquire majority control of the Company. As a result of the transaction, The David Cote Family is expected to have voting control of approximately 60% of total shares outstanding as of the closing date. A special committee of CompoSecure’s Board of Directors, which is comprised solely of independent directors and was formed in connection with the transaction (the “Special Committee”), after receiving advice from an independent legal counsel and financial advisor, unanimously approved the proposed transactions to which CompoSecure is a party. The transaction is expected to close by September 30, 2024, subject to customary closing conditions and regulatory approvals, including Hart-Scott-Rodino clearance. The Special Committee was advised by Potter Anderson & Corroon LLP (Wilmington, DE) as legal advisor and Houlihan Lokey, Inc. as financial advisor. Goldman Sachs & Co. LLC is serving as financial advisor to Resolute, and Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as legal advisor. J.P. Morgan acted as exclusive financial advisor to LLR Partners on the sale of its stake in CompoSecure to Resolute Holdings
Resolute Holdings I, LP completed the acquisition of 60% stake in CompoSecure, Inc. (NasdaqGM:CMPO) for approximately 370 million on September 17, 2024. In conjunction with the closing, David Cote has been appointed executive chairman of the board of directors of CompoSecure and Tom Knott, Joseph DeAngelo, Roger Fradin, Mark James, and John Cote have also been appointed to the board of directors. In accordance with the Letter Agreement, the Board approved the increase in the size of the Board from seven (7) directors to eleven (11) directors, Pursuant to the terms of the Resignation Letters, each of Hollin and Logan’s resignations became effective as of the Closing, on September 17, 2024. Ankündigung • Aug 08
CompoSecure, Inc. Revises Earnings Guidance for the Fiscal Year 2024 CompoSecure, Inc. revised earnings guidance for the fiscal year 2024. The company has narrowed its previously issued fiscal 2024 guidance and now expects net sales to range between $418 million to $428 million (previously $408 million to $428 million). Ankündigung • Jul 25
CompoSecure, Inc. to Report Q2, 2024 Results on Aug 07, 2024 CompoSecure, Inc. announced that they will report Q2, 2024 results on Aug 07, 2024 Major Estimate Revision • May 13
Consensus EPS estimates fall by 10%, revenue upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from US$418.3m to US$422.7m. EPS estimate fell from US$0.67 to US$0.60 per share. Net income forecast to grow 47% next year vs 11% growth forecast for Tech industry in the US. Consensus price target up from US$11.50 to US$12.30. Share price fell 7.7% to US$6.69 over the past week. Ankündigung • Apr 23
CompoSecure, Inc. to Report Q1, 2024 Results on May 06, 2024 CompoSecure, Inc. announced that they will report Q1, 2024 results on May 06, 2024 Ankündigung • Apr 20
CompoSecure, Inc., Annual General Meeting, May 30, 2024 CompoSecure, Inc., Annual General Meeting, May 30, 2024, at 10:00 US Eastern Standard Time. Agenda: To elect three Class III directors to serve on the Company’s Board of Directors for a term expiring at the 2027 annual meeting of stockholders and until their successors are duly elected and qualified, or until such director’s earlier resignation, removal or death; to ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024;and to transact such other business as may properly come before the Annual Meeting or any adjournment, adjournments or postponement thereof. Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to US$6.84, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 10x in the Tech industry in the US. Total loss to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$9.33 per share. New Risk • Mar 14
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Negative equity (-US$206m). Minor Risks Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Price Target Changed • Mar 09
Price target increased by 7.5% to US$11.50 Up from US$10.70, the current price target is an average from 5 analysts. New target price is 93% above last closing price of US$5.95. Stock is down 13% over the past year. The company is forecast to post earnings per share of US$0.86 for next year compared to US$1.03 last year. Ankündigung • Mar 08
CompoSecure, Inc. (NasdaqGM:CMPO) announces an Equity Buyback. CompoSecure, Inc. (NasdaqGM:CMPO) announces a share repurchase program. Under the program, the company will repurchase up to $40 million worth of its common stock, warrants and/or notes exchangeable for shares of common stock. Any shares of common stock repurchased under the program may either be returned to the status of authorized but unissued shares of common stock or held as treasury stock of the company. The repurchase program is valid till March 7, 2027. Ankündigung • Mar 07
CompoSecure, Inc. Provides Earnings Guidance for the Year 2024 CompoSecure, Inc. provided earnings guidance for the year 2024. The company expects net sales for the full year to range between $408 million to $428 million. Ankündigung • Feb 22
CompoSecure, Inc. to Report Q4, 2023 Results on Mar 06, 2024 CompoSecure, Inc. announced that they will report Q4, 2023 results on Mar 06, 2024 Price Target Changed • Feb 14
Price target decreased by 12% to US$10.70 Down from US$12.10, the current price target is an average from 5 analysts. New target price is 113% above last closing price of US$5.03. Stock is down 27% over the past year. The company is forecast to post earnings per share of US$0.90 for next year compared to US$1.21 last year. New Risk • Jan 23
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.9% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Negative equity (-US$239m). Minor Risks Shareholders have been diluted in the past year (3.9% increase in shares outstanding). Price Target Changed • Dec 17
Price target decreased by 8.7% to US$11.88 Down from US$13.00, the current price target is an average from 4 analysts. New target price is 142% above last closing price of US$4.91. Stock is down 1.6% over the past year. The company posted earnings per share of US$1.21 last year. New Risk • Dec 11
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.9% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Negative equity (-US$239m). Minor Risks Shareholders have been diluted in the past year (3.9% increase in shares outstanding). New Risk • Dec 10
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$94.8m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Negative equity (-US$239m). Minor Risks Market cap is less than US$100m (US$94.8m market cap). Ankündigung • Nov 12
CompoSecure, Inc. Revises Sales Guidance for the Full Year 2023 CompoSecure, Inc. revised sales guidance for the full year 2023. for the year, the company now expects net sales to be in the range of $386 million-$392 million (previously $400 million-$425 million). Ankündigung • Oct 27
CompoSecure, Inc. to Report Q3, 2023 Results on Nov 09, 2023 CompoSecure, Inc. announced that they will report Q3, 2023 results on Nov 09, 2023 New Risk • Sep 11
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Negative equity (-US$272m). Minor Risks Shareholders have been diluted in the past year (3.8% increase in shares outstanding). Major Estimate Revision • Aug 21
Consensus EPS estimates increase by 25%, revenue downgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from US$416.3m to US$405.5m. EPS estimate rose from US$0.692 to US$0.861. Net income forecast to grow 249% next year vs 20% growth forecast for Tech industry in the US. Consensus price target down from US$13.80 to US$12.80. Share price fell 3.0% to US$6.51 over the past week. Reported Earnings • Aug 15
Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2023 results: EPS: US$0.31 (down from US$0.56 in 2Q 2022). Revenue: US$98.5m (up 1.4% from 2Q 2022). Net income: US$5.74m (down 32% from 2Q 2022). Profit margin: 5.8% (down from 8.7% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) exceeded analyst estimates by 17%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Tech industry in the US. Ankündigung • Aug 08
CompoSecure, Inc. to Report Q2, 2023 Results on Aug 14, 2023 CompoSecure, Inc. announced that they will report Q2, 2023 results on Aug 14, 2023 Recent Insider Transactions Derivative • May 22
Chief Financial & Accounting Officer exercised options and sold US$743k worth of stock On the 17th of May, Timothy Fitzsimmons exercised 100k options at a strike price of around US$0.01 and sold these shares for an average price of US$7.44 per share. This trade did not impact their existing holding. Since March 2023, Timothy has owned 43.04k shares directly. Company insiders have collectively sold US$545k more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • May 05
Full year 2022 earnings released: EPS: US$1.21 (vs US$0.21 in FY 2021) Full year 2022 results: EPS: US$1.21 (up from US$0.21 in FY 2021). Revenue: US$378.5m (up 41% from FY 2021). Net income: US$18.7m (up 492% from FY 2021). Profit margin: 4.9% (up from 1.2% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Tech industry in the US. Ankündigung • May 05
CompoSecure, Inc. Provides Sales Guidance for Full Year 2023 CompoSecure, Inc. announced the Company is reaffirming its guidance for full year 2023 results, with net sales expected to be in the range of $400 million-$425 million. Major Estimate Revision • May 04
Consensus EPS estimates fall by 12% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from US$1.07 to US$0.935 per share. Revenue forecast steady at US$417.4m. Net income forecast to grow 250% next year vs 4.9% decline forecast for Tech industry in the US. Consensus price target of US$13.33 unchanged from last update. Share price fell 5.1% to US$7.00 over the past week. 
